XML 62 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Shareholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Shareholders’ Equity [Abstract]  
Schedule of Share Option Activity A summary of the Company’s share option activity and related information is as follows:
  

Number of
shares upon
exercise

   Weighted average exercise price  

Weighted- average remaining contractual term

(in years)

  

Aggregate intrinsic

value

 
                 
Outstanding at beginning of year   631,675   $49.32         5.83   $1,039 
Granted   65,036    16.48    -    - 
Exercised   (61,441)   11.63    -    1,069 
Forfeited   (41,349)   21.24    -    - 
                     
Outstanding at end of year   593,921   $46.95    5.55   $4,516 
                     
Exercisable at end of year   421,971   $47.37    4.37   $3,206 
Schedule of RSU’s Activity A summary of the Company’s RSU activity is as follows:
  

Number of
RSUs

 
     
Unvested at beginning of year   1,674,902 
Granted   1,412,810 
Vested   (603,213)
Forfeited   (325,776)
      
Unvested at the end of the year   2,158,723 
Schedule of Share Based Compensation Expense The following table sets forth the total share-based compensation expense included in the consolidated statements of operations for the years ended December 31, 2024, 2023 and 2022:
  

Year Ended December 31,

 
   2024   2023   2022 
             
Cost of products  $2,018   $2,356   $2,185 
Cost of services   1,703    1,758    1,676 
Research and development, net   5,310    5,759    5,312 
Sales and marketing   6,228    6,689    7,361 
General and administrative   6,497    6,027    6,115 
                
Total share-based compensation expenses  $21,756   $22,589   $22,649